ConductScience.org, home

Paper797495

Drug dosage in renal disease.

Dettli L. Clin Pharmacokinet, 1976. Cited by 91 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Drug dosage in renal disease. Papers, record 797495. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/797495

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Drug dosage in renal disease.
PubMed
Journal
Clin Pharmacokinet
PubMed
Year
1976
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
91
iCite
Relative citation ratio, by iCite
4.11
iCite
Revised in PubMed
2018-11-13
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dettli LL

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Kidney DiseasesMajor topic
Pharmaceutical PreparationsMajor topic
Creatinine
Drug Administration Schedule
Humans
Kinetics
Mathematics
Metabolic Clearance Rate
Models, Biological

Source PubMed

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,415,142Antimicrobial therapy in patients with renal insufficiency.Postgrad Med1970https://conductscience.org/library/papers/5415142PubMed
24,378,402Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.N Engl J Med1971https://conductscience.org/library/papers/4378402PubMed
35,046,120Drug elimination and apparent volume of distribution in multicompartment systems.J Pharm Sci1972https://conductscience.org/library/papers/5046120PubMed
45,819,419Correlation of serum creatinine concentration and kanamycin half-life. Therapeutic implications.JAMA1969https://conductscience.org/library/papers/5819419PubMed
51,150,365Calculation of drug dosage regimens in patients with renal disease: a new nomographic method.Int J Clin Pharmacol Biopharm1975https://conductscience.org/library/papers/1150365PubMed
64,359,016Pharmacokinetics and dosing of antimicrobial agents in renal impairment. I.Am J Hosp Pharm1974https://conductscience.org/library/papers/4359016PubMed
75,536,348A practical guide to drug usage in adult patients with impaired renal function.JAMA1970https://conductscience.org/library/papers/5536348PubMed
84,822,591Relevant pharmacokinetics of antimicrobial drugs.Med Clin North Am1974https://conductscience.org/library/papers/4822591PubMed
94,102,655Rapid evaluation of creatinine clearance.Lancet1971https://conductscience.org/library/papers/4102655PubMed
104,425,338Individualization of drug dosage in patients with renal disease.Med Clin North Am1974https://conductscience.org/library/papers/4425338PubMed
111,149,366Digoxin pharmacokinetics: role of renal failure in dosage regimen design.Clin Pharmacol Ther1975https://conductscience.org/library/papers/1149366PubMed
121,153,839A new simple and rapid method to monitor the renal function based on pharmacokinetic consideration of endogeneous creatinine=.Res Commun Chem Pathol Pharmacol1975https://conductscience.org/library/papers/1153839PubMed
135,010,514[How to prescribe drugs in the presence of functional renal deficiencies. Tables of dosage adjustment].Schweiz Med Wochenschr1972https://conductscience.org/library/papers/5010514PubMed
144,821,438Pharmacokinetics of cefazolin in normal and uremic subjects.Clin Pharmacol Ther1974https://conductscience.org/library/papers/4821438PubMed
154,843,318Drug dosage in patients with renal disease.Clin Pharmacol Ther1974https://conductscience.org/library/papers/4843318PubMed
1613,804,370The pathologic physiology of chronic Bright's disease. An exposition of the "intact nephron hypothesis".Am J Med1960https://conductscience.org/library/papers/13804370PubMed
176,028,645A guide to use of antibiotics in patients with renal disease. A table of recommended doses and factors governing serum levels.Ann Intern Med1967https://conductscience.org/library/papers/6028645PubMed
185,488,205Drug dosage in patients with impaired renal function.Postgrad Med J1970https://conductscience.org/library/papers/5488205PubMed
191,149,362Decreased plasma protein binding of diazoxide in uremia.Clin Pharmacol Ther1975https://conductscience.org/library/papers/1149362PubMed
201,149,361Prediction of drug dosage in patients with renal failure using data derived from normal subjects.Clin Pharmacol Ther1975https://conductscience.org/library/papers/1149361PubMed

See all 22 references

Cited by57

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.

PMIDTitleJournalYearIn PapersSource
42,426,424Physiologically based pharmacokinetic modeling of cefotaxime to inform pediatric dosing in renal impairment.Eur J Clin Pharmacol2026https://conductscience.org/library/papers/42426424PubMed
39,821,536Dosage Optimization Using Physiologically Based Pharmacokinetic Modeling for Pediatric Patients with Renal Impairment: A Case Study of Meropenem.AAPS PharmSciTech2025https://conductscience.org/library/papers/39821536PubMed
35,508,593Determining the Effects of Chronic Kidney Disease on Organic Anion Transporter1/3 Activity Through Physiologically Based Pharmacokinetic Modeling.Clin Pharmacokinet2022https://conductscience.org/library/papers/35508593PubMed
34,725,352Bridging the gap between in silico and in vivo by modeling opioid disposition in a kidney proximal tubule microphysiological system.Sci Rep2021https://conductscience.org/library/papers/34725352PubMed
31,375,913Pharmacokinetics in children with chronic kidney disease.Pediatr Nephrol2020https://conductscience.org/library/papers/31375913PubMed
29,546,450
[Dose adjustment of anti-infective drugs in patients with renal failure and renal replacement therapy in intensive care medicine : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI].
Med Klin Intensivmed Notfmed2018https://conductscience.org/library/papers/29546450PubMed
29,029,541Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?Oncotarget2017https://conductscience.org/library/papers/29029541PubMed
28,675,584Does Secretory Clearance Follow Glomerular Filtration Rate in Chronic Kidney Diseases? Reconsidering the Intact Nephron Hypothesis.Clin Transl Sci2017https://conductscience.org/library/papers/28675584PubMed
26,150,141Development of a computerised decisions support system for renal risk drugs targeting primary healthcare.BMJ Open2015https://conductscience.org/library/papers/26150141PubMed
26,017,400Suboptimal antimicrobial drug exposure in patients with renal impairment.Int J Clin Pharm2015https://conductscience.org/library/papers/26017400PubMed
25,855,244A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD.Semin Dial2015https://conductscience.org/library/papers/25855244PubMed
25,812,546[Antibiotic dosing for renal function disorders and continuous renal replacement therapy].Anaesthesist2015https://conductscience.org/library/papers/25812546PubMed
22,695,895[Pharmacotherapy in patients suffering from chronic kidney disease].Internist (Berl)2012https://conductscience.org/library/papers/22695895PubMed
22,242,561Pharmacokinetic predictions for patients with renal impairment: focus on peptides and protein drugs.Br J Clin Pharmacol2012https://conductscience.org/library/papers/22242561PubMed
20,959,896Drug therapy in patients with chronic renal failure.Dtsch Arztebl Int2010https://conductscience.org/library/papers/20959896PubMed
20,683,672[Questionnaire surveying nephrologists on drug dose adjustment in patients with impaired kidney function].Wien Klin Wochenschr2010https://conductscience.org/library/papers/20683672PubMed
16,247,710Pharmacokinetic significance of renal OAT3 (SLC22A8) for anionic drug elimination in patients with mesangial proliferative glomerulonephritis.Pharm Res2005https://conductscience.org/library/papers/16247710PubMed
14,984,259Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases.Pharm Res2004https://conductscience.org/library/papers/14984259PubMed
12,463,936Understanding usage patterns of handheld computers in clinical practice.Proc AMIA Symp2002https://conductscience.org/library/papers/12463936PubMed
11,708,763Pregnancy and renal failure: the case for application of dosage guidelines.Drugs2001https://conductscience.org/library/papers/11708763PubMed

See all 57 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/797495

GET https://conductscience.org/api/papers/v1/797495/references?page=2